

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.10212537 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.10212537 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.87016292 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.87016292 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 6.57064071 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.42856328 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20485314 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.92805050 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.82067648 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.82067648 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.82067648 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.75570661 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.68296555 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.66432378 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.49208215 |
| 16 | triglyceride catabolic process (GO:0019433) | 5.45723354 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.39380638 |
| 18 | cysteine metabolic process (GO:0006534) | 5.33326199 |
| 19 | NADH metabolic process (GO:0006734) | 5.31886250 |
| 20 | urea metabolic process (GO:0019627) | 5.22716962 |
| 21 | urea cycle (GO:0000050) | 5.22716962 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21820204 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.21197086 |
| 24 | lysine catabolic process (GO:0006554) | 5.03818068 |
| 25 | lysine metabolic process (GO:0006553) | 5.03818068 |
| 26 | neutral lipid catabolic process (GO:0046461) | 5.02340530 |
| 27 | acylglycerol catabolic process (GO:0046464) | 5.02340530 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.00536895 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.99484638 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89995487 |
| 31 | protein carboxylation (GO:0018214) | 4.89995487 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.88754439 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.85432625 |
| 34 | bile acid metabolic process (GO:0008206) | 4.85422244 |
| 35 | diacylglycerol metabolic process (GO:0046339) | 4.83521964 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.82178547 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.76725892 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.76276892 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.74442937 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.70032158 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.69406894 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.68592547 |
| 43 | regulation of protein activation cascade (GO:2000257) | 4.66068100 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.62017445 |
| 45 | regulation of sequestering of triglyceride (GO:0010889) | 4.61071249 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.56368931 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.56368931 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56368931 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.53593243 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.48080058 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.47804382 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.47804382 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.47635880 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.47635880 |
| 55 | fatty acid homeostasis (GO:0055089) | 4.39263540 |
| 56 | phospholipid efflux (GO:0033700) | 4.36586477 |
| 57 | regulation of complement activation (GO:0030449) | 4.35866334 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.32458995 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.24719474 |
| 60 | glycine metabolic process (GO:0006544) | 4.22334583 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.19329318 |
| 62 | ethanol oxidation (GO:0006069) | 4.16041535 |
| 63 | angiotensin maturation (GO:0002003) | 4.15637941 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.14539214 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.10084664 |
| 66 | glutamate metabolic process (GO:0006536) | 4.09542099 |
| 67 | regulation of cholesterol storage (GO:0010885) | 4.08930645 |
| 68 | lipoprotein transport (GO:0042953) | 4.08551856 |
| 69 | ketone body metabolic process (GO:1902224) | 4.08279401 |
| 70 | cellular glucuronidation (GO:0052695) | 4.07804694 |
| 71 | bile acid and bile salt transport (GO:0015721) | 4.07536463 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 4.07353478 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.06930949 |
| 74 | amine catabolic process (GO:0009310) | 4.01909618 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.01909618 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.99859363 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.96408372 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.94664796 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.94345368 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.94184812 |
| 81 | cholesterol efflux (GO:0033344) | 3.94125523 |
| 82 | intestinal absorption (GO:0050892) | 3.94057640 |
| 83 | fatty acid oxidation (GO:0019395) | 3.90244375 |
| 84 | drug catabolic process (GO:0042737) | 3.89949714 |
| 85 | regulation of plasminogen activation (GO:0010755) | 3.88130539 |
| 86 | organic acid catabolic process (GO:0016054) | 3.87653870 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.87653870 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86294010 |
| 89 | triglyceride biosynthetic process (GO:0019432) | 3.86191175 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.85396912 |
| 91 | ethanol metabolic process (GO:0006067) | 3.85252340 |
| 92 | lipid oxidation (GO:0034440) | 3.83745831 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.83634898 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.83585936 |
| 95 | carnitine metabolic process (GO:0009437) | 3.82437133 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.78270812 |
| 97 | aldehyde catabolic process (GO:0046185) | 3.77437553 |
| 98 | fatty acid catabolic process (GO:0009062) | 3.77172406 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74838682 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74838682 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.74135792 |
| 102 | arginine metabolic process (GO:0006525) | 3.73909747 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.73116162 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.71878064 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.71797830 |
| 106 | neutral lipid biosynthetic process (GO:0046460) | 3.70510934 |
| 107 | acylglycerol biosynthetic process (GO:0046463) | 3.70510934 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.66020152 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.65743703 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.65114392 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.63887625 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.63887625 |
| 113 | drug transmembrane transport (GO:0006855) | 3.63655142 |
| 114 | fibrinolysis (GO:0042730) | 3.63253120 |
| 115 | sterol homeostasis (GO:0055092) | 3.60882213 |
| 116 | cofactor catabolic process (GO:0051187) | 3.58801302 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58694300 |
| 118 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.55222901 |
| 119 | triglyceride metabolic process (GO:0006641) | 3.52519216 |
| 120 | oxaloacetate metabolic process (GO:0006107) | 3.50901413 |
| 121 | glycerolipid catabolic process (GO:0046503) | 3.50761193 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 3.46770765 |
| 123 | white fat cell differentiation (GO:0050872) | 3.45293006 |
| 124 | epoxygenase P450 pathway (GO:0019373) | 3.38313119 |
| 125 | desmosome organization (GO:0002934) | 3.32430848 |
| 126 | acylglycerol metabolic process (GO:0006639) | 3.30443097 |
| 127 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.25975959 |
| 128 | neutral lipid metabolic process (GO:0006638) | 3.24840094 |
| 129 | transcytosis (GO:0045056) | 3.24661199 |
| 130 | biotin metabolic process (GO:0006768) | 3.15134139 |
| 131 | lipid storage (GO:0019915) | 3.08033115 |
| 132 | primary alcohol catabolic process (GO:0034310) | 3.05907521 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.04058059 |
| 134 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.03085805 |
| 135 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.00172485 |
| 136 | daunorubicin metabolic process (GO:0044597) | 2.91856800 |
| 137 | polyketide metabolic process (GO:0030638) | 2.91856800 |
| 138 | doxorubicin metabolic process (GO:0044598) | 2.91856800 |
| 139 | cGMP-mediated signaling (GO:0019934) | 2.90687185 |
| 140 | fatty acid transmembrane transport (GO:1902001) | 2.88897329 |
| 141 | * primary alcohol metabolic process (GO:0034308) | 2.85888670 |
| 142 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.84881578 |
| 143 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.84614948 |
| 144 | very long-chain fatty acid metabolic process (GO:0000038) | 2.84613983 |
| 145 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.84371391 |
| 146 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.83775484 |
| 147 | acyl-CoA biosynthetic process (GO:0071616) | 2.82621160 |
| 148 | thioester biosynthetic process (GO:0035384) | 2.82621160 |
| 149 | regulation of cholesterol transport (GO:0032374) | 2.82239467 |
| 150 | regulation of sterol transport (GO:0032371) | 2.82239467 |
| 151 | regulation of cholesterol metabolic process (GO:0090181) | 2.82140160 |
| 152 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.81771313 |
| 153 | carnitine shuttle (GO:0006853) | 2.79387689 |
| 154 | lipoprotein metabolic process (GO:0042157) | 2.78186433 |
| 155 | positive regulation of cholesterol efflux (GO:0010875) | 2.77576254 |
| 156 | negative regulation of fatty acid transport (GO:2000192) | 2.77518307 |
| 157 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.77449293 |
| 158 | fructose metabolic process (GO:0006000) | 2.76519678 |
| 159 | positive regulation of lipid storage (GO:0010884) | 2.76424179 |
| 160 | glycerol metabolic process (GO:0006071) | 2.75584595 |
| 161 | brown fat cell differentiation (GO:0050873) | 2.74023670 |
| 162 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.72701168 |
| 163 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71506083 |
| 164 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.69296887 |
| 165 | linoleic acid metabolic process (GO:0043651) | 2.67748228 |
| 166 | thioester metabolic process (GO:0035383) | 2.67219221 |
| 167 | acyl-CoA metabolic process (GO:0006637) | 2.67219221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21136239 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.11845309 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54663684 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.37549969 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.08869787 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97810920 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81343524 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.52961218 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89046853 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77146267 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.76374031 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66575505 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18701556 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05258067 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5423928 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91699088 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84355628 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69149295 |
| 19 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60056512 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56908418 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54923397 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45433856 |
| 23 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44201714 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42891857 |
| 25 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41605855 |
| 26 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40610833 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39022511 |
| 28 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37158970 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33901798 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30582157 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28394112 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22340936 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20522967 |
| 34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20138192 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19936314 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18965616 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15465446 |
| 38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15317429 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13961827 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12801404 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10935950 |
| 42 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10483585 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09839064 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08285393 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07010639 |
| 46 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06760476 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06297596 |
| 48 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04519404 |
| 49 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04382649 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02712105 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02495788 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02042143 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01035456 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00153783 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00099954 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99361219 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98847146 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96988107 |
| 59 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96413672 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95494414 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94838917 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94720537 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94313980 |
| 64 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92861443 |
| 65 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92680527 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 0.91900100 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91769840 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90828345 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90828345 |
| 70 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90727042 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90324490 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89643850 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89433928 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89346714 |
| 75 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88943998 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88150561 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87998683 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87577743 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87488475 |
| 80 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.86861353 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86781082 |
| 82 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85894510 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85824322 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84477738 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83690785 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81377906 |
| 87 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79717399 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77492416 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77369351 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77067895 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75920215 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75299694 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71879395 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71740829 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71374719 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71150369 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70997379 |
| 98 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70916477 |
| 99 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67131865 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66908290 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66634187 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65645283 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62788234 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62788234 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62174898 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61152527 |
| 107 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60918055 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60648349 |
| 109 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60631516 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55759420 |
| 111 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54822031 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54548962 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53809324 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52589591 |
| 115 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50451846 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50221571 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50162738 |
| 118 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.49114062 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48448412 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48053376 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47080667 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47069564 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46691511 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46633612 |
| 125 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46213654 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45365729 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44887105 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.44863430 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44283877 |
| 130 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.43834365 |
| 131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.43834365 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.43528955 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43434749 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42827476 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42244642 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42105469 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42035184 |
| 138 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.41409546 |
| 139 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41065416 |
| 140 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41024150 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39761196 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.38959626 |
| 143 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.38230246 |
| 144 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38094323 |
| 145 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37936545 |
| 146 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.36195640 |
| 147 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.36145341 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.35777037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.11849048 |
| 2 | MP0005360_urolithiasis | 7.37392629 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.08698371 |
| 4 | MP0005365_abnormal_bile_salt | 6.04632437 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.90454025 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18713389 |
| 7 | MP0003252_abnormal_bile_duct | 3.81196635 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.55569537 |
| 9 | MP0009840_abnormal_foam_cell | 3.32419990 |
| 10 | MP0005332_abnormal_amino_acid | 2.95575766 |
| 11 | MP0005083_abnormal_biliary_tract | 2.87565056 |
| 12 | MP0003195_calcinosis | 2.79082076 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56270514 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.41351292 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.24843608 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.17891593 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.17361784 |
| 18 | MP0000609_abnormal_liver_physiology | 2.14270376 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.95940461 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.92752489 |
| 21 | MP0000003_abnormal_adipose_tissue | 1.91139129 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.89316819 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.88120882 |
| 24 | MP0003868_abnormal_feces_composition | 1.70808408 |
| 25 | MP0005451_abnormal_body_composition | 1.69704174 |
| 26 | MP0005409_darkened_coat_color | 1.69272154 |
| 27 | MP0001764_abnormal_homeostasis | 1.66981740 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.65069829 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64053796 |
| 30 | MP0005275_abnormal_skin_tensile | 1.57481071 |
| 31 | MP0006138_congestive_heart_failure | 1.48215507 |
| 32 | MP0004272_abnormal_basement_membrane | 1.48164876 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.48006830 |
| 34 | MP0003186_abnormal_redox_activity | 1.47573709 |
| 35 | MP0003959_abnormal_lean_body | 1.43050935 |
| 36 | MP0009697_abnormal_copulation | 1.34153931 |
| 37 | MP0003011_delayed_dark_adaptation | 1.33206767 |
| 38 | MP0005670_abnormal_white_adipose | 1.32548352 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.27066488 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.26509531 |
| 41 | MP0000751_myopathy | 1.18672354 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.17309249 |
| 43 | MP0000598_abnormal_liver_morphology | 1.14533889 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.11938195 |
| 45 | MP0004130_abnormal_muscle_cell | 1.07377070 |
| 46 | MP0005647_abnormal_sex_gland | 1.07336533 |
| 47 | MP0004858_abnormal_nervous_system | 1.05817451 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.05424513 |
| 49 | MP0003828_pulmonary_edema | 1.05131369 |
| 50 | MP0009764_decreased_sensitivity_to | 1.04421231 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.02115853 |
| 52 | MP0000604_amyloidosis | 1.00981313 |
| 53 | MP0000858_altered_metastatic_potential | 0.99679534 |
| 54 | MP0002254_reproductive_system_inflammat | 0.99093676 |
| 55 | MP0009763_increased_sensitivity_to | 0.95555732 |
| 56 | MP0003879_abnormal_hair_cell | 0.93433207 |
| 57 | MP0009379_abnormal_foot_pigmentation | 0.92874337 |
| 58 | MP0002971_abnormal_brown_adipose | 0.92448657 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 0.92281005 |
| 60 | MP0005257_abnormal_intraocular_pressure | 0.91471889 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 0.88332175 |
| 62 | MP0001756_abnormal_urination | 0.87562894 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.86874901 |
| 64 | MP0008469_abnormal_protein_level | 0.86192620 |
| 65 | MP0005023_abnormal_wound_healing | 0.85417779 |
| 66 | MP0002060_abnormal_skin_morphology | 0.85157717 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.83528592 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.83457626 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.83205070 |
| 70 | MP0003279_aneurysm | 0.83172928 |
| 71 | MP0005452_abnormal_adipose_tissue | 0.82737488 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.82559080 |
| 73 | MP0002896_abnormal_bone_mineralization | 0.81885173 |
| 74 | MP0001958_emphysema | 0.81531640 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.81114724 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.80686369 |
| 77 | MP0005334_abnormal_fat_pad | 0.80618199 |
| 78 | MP0005503_abnormal_tendon_morphology | 0.79625470 |
| 79 | MP0001849_ear_inflammation | 0.78950155 |
| 80 | MP0005501_abnormal_skin_physiology | 0.77030560 |
| 81 | MP0005535_abnormal_body_temperature | 0.76745967 |
| 82 | MP0003091_abnormal_cell_migration | 0.74781494 |
| 83 | MP0005266_abnormal_metabolism | 0.73877972 |
| 84 | MP0005165_increased_susceptibility_to | 0.73412745 |
| 85 | MP0003690_abnormal_glial_cell | 0.72986850 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.72543592 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.72449877 |
| 88 | MP0005408_hypopigmentation | 0.72414441 |
| 89 | MP0001661_extended_life_span | 0.72304805 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.72274964 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.72091857 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.70235985 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.68812867 |
| 94 | MP0000343_altered_response_to | 0.67091469 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.66329060 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.65959563 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.65754843 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.65218638 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.65080651 |
| 100 | MP0004043_abnormal_pH_regulation | 0.64569702 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.63969569 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.63917608 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.62915356 |
| 104 | MP0003329_amyloid_beta_deposits | 0.60742451 |
| 105 | MP0002933_joint_inflammation | 0.60289380 |
| 106 | MP0005448_abnormal_energy_balance | 0.59990204 |
| 107 | MP0002909_abnormal_adrenal_gland | 0.59852812 |
| 108 | MP0005220_abnormal_exocrine_pancreas | 0.58816122 |
| 109 | MP0004947_skin_inflammation | 0.58634242 |
| 110 | MP0009115_abnormal_fat_cell | 0.53367993 |
| 111 | MP0009053_abnormal_anal_canal | 0.53261176 |
| 112 | MP0003724_increased_susceptibility_to | 0.50172234 |
| 113 | MP0005395_other_phenotype | 0.47601662 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.47571237 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.46887054 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.45914868 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.45665415 |
| 118 | MP0003953_abnormal_hormone_level | 0.43828366 |
| 119 | MP0002970_abnormal_white_adipose | 0.43731355 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.43371870 |
| 121 | MP0001853_heart_inflammation | 0.43241271 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.43186920 |
| 123 | MP0002796_impaired_skin_barrier | 0.42180949 |
| 124 | MP0003075_altered_response_to | 0.42022770 |
| 125 | MP0002928_abnormal_bile_duct | 0.41180053 |
| 126 | MP0008874_decreased_physiological_sensi | 0.40549980 |
| 127 | MP0008873_increased_physiological_sensi | 0.39932531 |
| 128 | MP0002168_other_aberrant_phenotype | 0.39088953 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.39065256 |
| 130 | MP0003718_maternal_effect | 0.36500240 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.36281263 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.36092012 |
| 133 | MP0005166_decreased_susceptibility_to | 0.35940268 |
| 134 | MP0009672_abnormal_birth_weight | 0.35504696 |
| 135 | MP0000249_abnormal_blood_vessel | 0.35294423 |
| 136 | MP0003436_decreased_susceptibility_to | 0.35010997 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.33226990 |
| 138 | MP0008872_abnormal_physiological_respon | 0.32570012 |
| 139 | MP0005330_cardiomyopathy | 0.31274162 |
| 140 | MP0001881_abnormal_mammary_gland | 0.30824797 |
| 141 | MP0005248_abnormal_Harderian_gland | 0.30192048 |
| 142 | MP0001243_abnormal_dermal_layer | 0.29747912 |
| 143 | MP0004883_abnormal_blood_vessel | 0.29203617 |
| 144 | MP0002269_muscular_atrophy | 0.28478407 |
| 145 | MP0002822_catalepsy | 0.28316819 |
| 146 | MP0005164_abnormal_response_to | 0.28287595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.79888826 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.70296847 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.60877638 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.13659243 |
| 5 | Xanthomatosis (HP:0000991) | 6.12156754 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.93481402 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.71225328 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.32180654 |
| 9 | Hyperammonemia (HP:0001987) | 4.82970383 |
| 10 | Complement deficiency (HP:0004431) | 4.66001902 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.61639637 |
| 12 | Hyperglycinuria (HP:0003108) | 4.60742744 |
| 13 | Hyperglycinemia (HP:0002154) | 4.57085789 |
| 14 | Ketosis (HP:0001946) | 4.54289245 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.42446374 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.42446374 |
| 17 | Epidermoid cyst (HP:0200040) | 4.29512806 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26510028 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24402596 |
| 20 | Joint hemorrhage (HP:0005261) | 4.23587603 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.20046651 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.19203437 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17106692 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15958502 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.02928656 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.00853883 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.85229932 |
| 28 | Fat malabsorption (HP:0002630) | 3.81325006 |
| 29 | Protrusio acetabuli (HP:0003179) | 3.65185545 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.64909873 |
| 31 | Acanthosis nigricans (HP:0000956) | 3.55155035 |
| 32 | Ketoacidosis (HP:0001993) | 3.53734640 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.53283042 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.46929521 |
| 35 | Abnormality of complement system (HP:0005339) | 3.39350210 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37570131 |
| 37 | Oligomenorrhea (HP:0000876) | 3.36159337 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.29196773 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 3.20053836 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20053836 |
| 41 | Ileus (HP:0002595) | 3.19823275 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.17872614 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.17822214 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17655520 |
| 45 | Delayed CNS myelination (HP:0002188) | 3.17446247 |
| 46 | Metabolic acidosis (HP:0001942) | 3.03401631 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.99841759 |
| 48 | Vertebral compression fractures (HP:0002953) | 2.99664537 |
| 49 | Gout (HP:0001997) | 2.86835816 |
| 50 | Steatorrhea (HP:0002570) | 2.86098500 |
| 51 | Lethargy (HP:0001254) | 2.83374565 |
| 52 | Myocardial infarction (HP:0001658) | 2.80559396 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.80115503 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 2.71481697 |
| 55 | Skin nodule (HP:0200036) | 2.71395243 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.61782133 |
| 57 | Flat acetabular roof (HP:0003180) | 2.61252446 |
| 58 | Vascular calcification (HP:0004934) | 2.57055310 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.55331247 |
| 60 | Cerebral edema (HP:0002181) | 2.55188111 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.46871277 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.46601352 |
| 63 | Malnutrition (HP:0004395) | 2.45725730 |
| 64 | Insulin resistance (HP:0000855) | 2.44226298 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.43993615 |
| 66 | Spastic diplegia (HP:0001264) | 2.43299850 |
| 67 | Back pain (HP:0003418) | 2.43247715 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.43116922 |
| 69 | Spontaneous abortion (HP:0005268) | 2.40065224 |
| 70 | Proximal tubulopathy (HP:0000114) | 2.39036919 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.37764426 |
| 72 | Vomiting (HP:0002013) | 2.37274476 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.35323329 |
| 74 | Cholelithiasis (HP:0001081) | 2.33321235 |
| 75 | Irritability (HP:0000737) | 2.32829337 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.31077547 |
| 77 | Cholecystitis (HP:0001082) | 2.31077547 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.29251756 |
| 79 | Acanthocytosis (HP:0001927) | 2.27145783 |
| 80 | Pancreatitis (HP:0001733) | 2.27069788 |
| 81 | Neonatal onset (HP:0003623) | 2.26884720 |
| 82 | Growth hormone excess (HP:0000845) | 2.26534103 |
| 83 | Thin bony cortex (HP:0002753) | 2.23119180 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.22645848 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.22645848 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.21441545 |
| 87 | Brushfield spots (HP:0001088) | 2.19096625 |
| 88 | Axonal loss (HP:0003447) | 2.17001038 |
| 89 | Nephritis (HP:0000123) | 2.16424711 |
| 90 | Late onset (HP:0003584) | 2.15970155 |
| 91 | Increased connective tissue (HP:0009025) | 2.15209646 |
| 92 | Renal cortical cysts (HP:0000803) | 2.14064717 |
| 93 | Hyperuricemia (HP:0002149) | 2.13161231 |
| 94 | Increased purine levels (HP:0004368) | 2.13161231 |
| 95 | Mitral stenosis (HP:0001718) | 2.12998988 |
| 96 | Alkalosis (HP:0001948) | 2.12306310 |
| 97 | Enlarged kidneys (HP:0000105) | 2.11785932 |
| 98 | Esophageal varix (HP:0002040) | 2.10838340 |
| 99 | Amyloidosis (HP:0011034) | 2.10089118 |
| 100 | Nausea (HP:0002018) | 2.08842688 |
| 101 | Abnormal ossification of hand bones (HP:0005921) | 2.08780866 |
| 102 | Rhabdomyolysis (HP:0003201) | 2.08147259 |
| 103 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.07921937 |
| 104 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.07755903 |
| 105 | Glycosuria (HP:0003076) | 2.07576686 |
| 106 | Abnormality of urine glucose concentration (HP:0011016) | 2.07576686 |
| 107 | Abnormal tarsal ossification (HP:0008369) | 2.06191728 |
| 108 | Glomerulonephritis (HP:0000099) | 2.06054337 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 2.05622959 |
| 110 | Cerebral aneurysm (HP:0004944) | 2.04239897 |
| 111 | Rickets (HP:0002748) | 2.03525076 |
| 112 | Opisthotonus (HP:0002179) | 2.02591714 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 2.02373279 |
| 114 | Hyperalaninemia (HP:0003348) | 2.02373279 |
| 115 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02373279 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01970589 |
| 117 | Vascular tortuosity (HP:0004948) | 2.00509809 |
| 118 | Widely patent fontanelles and sutures (HP:0004492) | 2.00207084 |
| 119 | Cervical subluxation (HP:0003308) | 1.99656673 |
| 120 | Polycythemia (HP:0001901) | 1.98127018 |
| 121 | Polygenic inheritance (HP:0010982) | 1.96260308 |
| 122 | Visceral angiomatosis (HP:0100761) | 1.95040146 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.94922825 |
| 124 | Hyperparathyroidism (HP:0000843) | 1.94094842 |
| 125 | Focal segmental glomerulosclerosis (HP:0000097) | 1.92892525 |
| 126 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92631685 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92541438 |
| 128 | Hemorrhage of the eye (HP:0011885) | 1.92265193 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 1.91814051 |
| 130 | Abnormality of the gallbladder (HP:0005264) | 1.91128110 |
| 131 | Hypertriglyceridemia (HP:0002155) | 1.91065929 |
| 132 | Arterial tortuosity (HP:0005116) | 1.90504094 |
| 133 | Aortic aneurysm (HP:0004942) | 1.88880411 |
| 134 | Menorrhagia (HP:0000132) | 1.88219983 |
| 135 | Elevated hepatic transaminases (HP:0002910) | 1.85735426 |
| 136 | Wide cranial sutures (HP:0010537) | 1.85083690 |
| 137 | Thrombophlebitis (HP:0004418) | 1.83801449 |
| 138 | Abnormal hand bone ossification (HP:0010660) | 1.83521374 |
| 139 | Hypophosphatemia (HP:0002148) | 1.83516247 |
| 140 | Gingival bleeding (HP:0000225) | 1.83371233 |
| 141 | Hemangiomatosis (HP:0007461) | 1.82912582 |
| 142 | Increased serum pyruvate (HP:0003542) | 1.82794578 |
| 143 | Abnormality of vitamin metabolism (HP:0100508) | 1.82720095 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82309769 |
| 145 | Wormian bones (HP:0002645) | 1.80221592 |
| 146 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78373189 |
| 147 | Hypercortisolism (HP:0001578) | 1.77968907 |
| 148 | Exercise-induced myalgia (HP:0003738) | 1.77410974 |
| 149 | Multiple lipomas (HP:0001012) | 1.77027199 |
| 150 | Subcapsular cataract (HP:0000523) | 1.76938700 |
| 151 | Gastrointestinal dysmotility (HP:0002579) | 1.76499544 |
| 152 | Biconcave vertebral bodies (HP:0004586) | 1.75092579 |
| 153 | Spinal rigidity (HP:0003306) | 1.72778507 |
| 154 | Osteolytic defects of the hand bones (HP:0009699) | 1.72222395 |
| 155 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72222395 |
| 156 | Abnormal glucose tolerance (HP:0001952) | 1.72199027 |
| 157 | Stroke (HP:0001297) | 1.71416554 |
| 158 | Aneurysm (HP:0002617) | 1.71102343 |
| 159 | Glomerulosclerosis (HP:0000096) | 1.70240303 |
| 160 | Cerebral inclusion bodies (HP:0100314) | 1.69637572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.57894043 |
| 2 | ERN1 | 4.45757748 |
| 3 | SIK1 | 4.38928045 |
| 4 | FGFR4 | 3.81463501 |
| 5 | EPHB2 | 2.63785781 |
| 6 | EPHA2 | 2.56831548 |
| 7 | PKN2 | 2.56290589 |
| 8 | INSRR | 2.54235007 |
| 9 | TRIB3 | 2.45069253 |
| 10 | TAOK3 | 2.37632693 |
| 11 | MST1R | 2.33786478 |
| 12 | ERBB4 | 2.15744914 |
| 13 | DDR2 | 2.07420579 |
| 14 | PRPF4B | 2.00115274 |
| 15 | FLT3 | 1.98797674 |
| 16 | PIK3CG | 1.80261944 |
| 17 | MAP2K4 | 1.78014496 |
| 18 | EEF2K | 1.76060942 |
| 19 | TESK1 | 1.70102670 |
| 20 | MAPK11 | 1.69704051 |
| 21 | ACVR1B | 1.48279624 |
| 22 | TYK2 | 1.47729643 |
| 23 | NEK9 | 1.46406718 |
| 24 | ABL2 | 1.44172890 |
| 25 | SMG1 | 1.38381139 |
| 26 | PTK6 | 1.38230935 |
| 27 | LATS1 | 1.37220992 |
| 28 | PRKAA2 | 1.34260529 |
| 29 | FRK | 1.33797742 |
| 30 | PAK4 | 1.31688790 |
| 31 | PDK4 | 1.31683009 |
| 32 | PDK3 | 1.31683009 |
| 33 | MAP2K3 | 1.30857943 |
| 34 | LATS2 | 1.30095139 |
| 35 | KDR | 1.28744227 |
| 36 | MAP3K7 | 1.24106590 |
| 37 | PINK1 | 1.23428588 |
| 38 | CAMK1D | 1.21940399 |
| 39 | PRKG2 | 1.14777778 |
| 40 | FGFR2 | 1.13136034 |
| 41 | TIE1 | 1.12090126 |
| 42 | STK38L | 1.10988850 |
| 43 | JAK3 | 1.10896849 |
| 44 | TTN | 1.06812407 |
| 45 | JAK2 | 1.06116100 |
| 46 | CDK9 | 1.04640649 |
| 47 | MAP3K3 | 1.04605490 |
| 48 | TBK1 | 1.01062565 |
| 49 | GRK6 | 0.99083908 |
| 50 | MET | 0.97179647 |
| 51 | IRAK3 | 0.95927357 |
| 52 | MAP3K1 | 0.94600976 |
| 53 | CDC42BPA | 0.94121604 |
| 54 | KSR2 | 0.93404782 |
| 55 | NTRK1 | 0.91679851 |
| 56 | MAP3K2 | 0.90691718 |
| 57 | MAPK4 | 0.90410307 |
| 58 | WNK3 | 0.89324475 |
| 59 | DAPK2 | 0.89006609 |
| 60 | JAK1 | 0.88326406 |
| 61 | MAP3K11 | 0.87882672 |
| 62 | MAPK12 | 0.87773366 |
| 63 | RIPK1 | 0.87157755 |
| 64 | MAPKAPK3 | 0.85525793 |
| 65 | PDK2 | 0.84517829 |
| 66 | TGFBR2 | 0.82192091 |
| 67 | MAP3K10 | 0.80754959 |
| 68 | PRKAA1 | 0.80501990 |
| 69 | CDK6 | 0.80064079 |
| 70 | EPHB1 | 0.79719697 |
| 71 | PIM2 | 0.79003247 |
| 72 | WNK4 | 0.78271031 |
| 73 | ARAF | 0.75321002 |
| 74 | PRKACG | 0.74859650 |
| 75 | ERBB2 | 0.74699874 |
| 76 | PRKCZ | 0.73014901 |
| 77 | GSK3A | 0.72443705 |
| 78 | MAP3K13 | 0.70592170 |
| 79 | PDGFRB | 0.69462097 |
| 80 | MAPK15 | 0.67462920 |
| 81 | MAP3K14 | 0.67238802 |
| 82 | ZAP70 | 0.66720413 |
| 83 | OXSR1 | 0.65721985 |
| 84 | CSK | 0.64773100 |
| 85 | MAP2K6 | 0.64679391 |
| 86 | FER | 0.64398705 |
| 87 | SGK3 | 0.63497991 |
| 88 | DYRK1B | 0.60970635 |
| 89 | PDPK1 | 0.60338816 |
| 90 | CAMK1 | 0.58240484 |
| 91 | AKT3 | 0.56609131 |
| 92 | CSF1R | 0.55994244 |
| 93 | TAOK2 | 0.55804072 |
| 94 | NEK1 | 0.54891451 |
| 95 | STK38 | 0.54626592 |
| 96 | PRKD2 | 0.53931677 |
| 97 | MYLK | 0.53166945 |
| 98 | TRPM7 | 0.52529507 |
| 99 | MAPK7 | 0.50647174 |
| 100 | CAMK2G | 0.50619711 |
| 101 | CAMK1G | 0.49191106 |
| 102 | RIPK4 | 0.48582753 |
| 103 | FGR | 0.48515974 |
| 104 | PTK2 | 0.45509766 |
| 105 | PIK3CA | 0.45451205 |
| 106 | IGF1R | 0.45096309 |
| 107 | PAK2 | 0.44939344 |
| 108 | MAP3K5 | 0.44854535 |
| 109 | CDK4 | 0.43669050 |
| 110 | RPS6KA2 | 0.42491799 |
| 111 | SCYL2 | 0.41489389 |
| 112 | TYRO3 | 0.41268526 |
| 113 | SRC | 0.40779898 |
| 114 | OBSCN | 0.40669861 |
| 115 | PRKCQ | 0.40583589 |
| 116 | MAP2K1 | 0.40234827 |
| 117 | FGFR3 | 0.40023310 |
| 118 | RPS6KB2 | 0.39889023 |
| 119 | SGK2 | 0.39859647 |
| 120 | PRKD1 | 0.38884089 |
| 121 | CDK12 | 0.38461377 |
| 122 | GRK1 | 0.38094961 |
| 123 | PDK1 | 0.37915327 |
| 124 | MTOR | 0.37891340 |
| 125 | MARK2 | 0.37769526 |
| 126 | IKBKE | 0.37262175 |
| 127 | EPHA3 | 0.37002701 |
| 128 | SGK494 | 0.36790566 |
| 129 | SGK223 | 0.36790566 |
| 130 | MAP3K6 | 0.36656842 |
| 131 | PBK | 0.36113078 |
| 132 | LMTK2 | 0.36087865 |
| 133 | YES1 | 0.35185203 |
| 134 | PRKD3 | 0.34787740 |
| 135 | MOS | 0.34272181 |
| 136 | AKT2 | 0.33733225 |
| 137 | BMX | 0.29559798 |
| 138 | CAMK4 | 0.26542704 |
| 139 | RET | 0.24988349 |
| 140 | MAP2K2 | 0.24361559 |
| 141 | EGFR | 0.23409181 |
| 142 | PRKCA | 0.22563278 |
| 143 | ICK | 0.21789963 |
| 144 | CSNK1G1 | 0.20746739 |
| 145 | PDGFRA | 0.20415029 |
| 146 | ABL1 | 0.20069436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14953897 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26223886 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21771482 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02440913 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83186043 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.79842855 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79319125 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74989877 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71266311 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68031499 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43462641 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36623291 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36503922 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34236060 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27913492 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.21706985 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13889869 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10189816 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02112795 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88052355 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84520157 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83645078 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83538020 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81837713 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81672901 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.80749918 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75182600 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66674451 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65038290 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58735464 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57472760 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56540099 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53157113 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52424088 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48283636 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47481740 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.47410371 |
| 38 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.46854131 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46409570 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41867921 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40798347 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36070018 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34314484 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31806797 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25168983 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24305212 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22797223 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22221513 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14218521 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07487193 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01417120 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01090019 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00073756 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99560451 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98923419 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98275067 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96574797 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94005607 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92708165 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.89754543 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85322693 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83689994 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82752982 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82169458 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79321779 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76258538 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68085611 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67360399 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66226085 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50504546 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43252136 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40134927 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.37593625 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37542636 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.37122447 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32750900 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.32636901 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32582654 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32413985 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.29659409 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28727795 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.27698707 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27517432 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24387108 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23302218 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21324459 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.20512440 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18034019 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17902146 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.16889965 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15948344 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.14567028 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14189792 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13310622 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12846563 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11833543 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10902502 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09589204 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2225407 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2180739 |
| 101 | Lysosome_Homo sapiens_hsa04142 | -0.2100594 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2087549 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2028538 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2018090 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1924701 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1793682 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1722690 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1702636 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1633692 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1631983 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | -0.1620677 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1281430 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1014744 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0777061 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0668905 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0499748 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0344866 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0037720 |

